153 related articles for article (PubMed ID: 22878344)
1. Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death.
Heinhuis B; Netea MG; van den Berg WB; Dinarello CA; Joosten LA
Cytokine; 2012 Nov; 60(2):321-7. PubMed ID: 22878344
[TBL] [Abstract][Full Text] [Related]
2. IL-32: a newly-discovered proinflammatory cytokine.
Felaco P; Castellani ML; De Lutiis MA; Felaco M; Pandolfi F; Salini V; De Amicis D; Vecchiet J; Tete S; Ciampoli C; Conti F; Cerulli G; Caraffa A; Antinolfi P; Cuccurullo C; Perrella A; Theoharides TC; Conti P; Toniato E; Kempuraj D; Shaik YB
J Biol Regul Homeost Agents; 2009; 23(3):141-7. PubMed ID: 19828090
[TBL] [Abstract][Full Text] [Related]
3. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility.
Andersson A; Kokkola R; Wefer J; Erlandsson-Harris H; Harris RA
J Leukoc Biol; 2004 Dec; 76(6):1118-24. PubMed ID: 15371491
[TBL] [Abstract][Full Text] [Related]
4. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
[TBL] [Abstract][Full Text] [Related]
5. IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense.
Larochette V; Miot C; Poli C; Beaumont E; Roingeard P; Fickenscher H; Jeannin P; Delneste Y
Front Immunol; 2019; 10():204. PubMed ID: 30809226
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
[TBL] [Abstract][Full Text] [Related]
7. IL-12 and IL-23: master regulators of innate and adaptive immunity.
Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
[TBL] [Abstract][Full Text] [Related]
8. Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19.
Fietta P; Costa E; Delsante G
Theor Biol Forum; 2014; 107(1-2):13-45. PubMed ID: 25936211
[TBL] [Abstract][Full Text] [Related]
9. Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B.
Huang Z; van Velkinburgh JC; Ni B; Wu Y
Liver Int; 2012 Jul; 32(6):894-901. PubMed ID: 22340646
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa.
Wolk K; Warszawska K; Hoeflich C; Witte E; Schneider-Burrus S; Witte K; Kunz S; Buss A; Roewert HJ; Krause M; Lukowsky A; Volk HD; Sterry W; Sabat R
J Immunol; 2011 Jan; 186(2):1228-39. PubMed ID: 21148041
[TBL] [Abstract][Full Text] [Related]
11. Intracellular galectin-9 activates inflammatory cytokines in monocytes.
Matsuura A; Tsukada J; Mizobe T; Higashi T; Mouri F; Tanikawa R; Yamauchi A; Hirashima M; Tanaka Y
Genes Cells; 2009 Apr; 14(4):511-21. PubMed ID: 19335620
[TBL] [Abstract][Full Text] [Related]
12. Regulation of interleukin-10 and interleukin-22 expression in T helper cells.
Rutz S; Ouyang W
Curr Opin Immunol; 2011 Oct; 23(5):605-12. PubMed ID: 21862302
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
Andersson AK; Feldmann M; Brennan FM
Scand J Immunol; 2008 Jul; 68(1):103-11. PubMed ID: 18482208
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-32: An endogenous danger signal or master regulator of intracellular pathogen infections-Focus on leishmaniases.
Dos Santos JC; Damen MSMA; Joosten LAB; Ribeiro-Dias F
Semin Immunol; 2018 Aug; 38():15-23. PubMed ID: 29551246
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice.
Zhiguang X; Wei C; Steven R; Wei D; Wei Z; Rong M; Zhanguo L; Lianfeng Z
Immunol Lett; 2010 Jul; 131(2):159-65. PubMed ID: 20412815
[TBL] [Abstract][Full Text] [Related]
16. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
[TBL] [Abstract][Full Text] [Related]
17. IL-27: a double agent in the IL-6 family.
Jones GW; Hill DG; Cardus A; Jones SA
Clin Exp Immunol; 2018 Jul; 193(1):37-46. PubMed ID: 29437229
[TBL] [Abstract][Full Text] [Related]
18. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.
Wu PW; Li J; Kodangattil SR; Luxenberg DP; Bennett F; Martino M; Collins M; Dunussi-Joannopoulos K; Gill DS; Wolfman NM; Fouser LA
J Mol Biol; 2008 Oct; 382(5):1168-83. PubMed ID: 18675824
[TBL] [Abstract][Full Text] [Related]
19. Long-term exposure to IL-1beta enhances Toll-IL-1 receptor-mediated inflammatory signaling in murine airway hyperresponsiveness.
Zhang Y; Xu CB; Cardell LO
Eur Cytokine Netw; 2009 Sep; 20(3):148-56. PubMed ID: 19825525
[TBL] [Abstract][Full Text] [Related]
20. The association between maternal cervicovaginal proinflammatory cytokines concentrations during pregnancy and subsequent early-onset neonatal infection.
Kalinka J; Krajewski P; Sobala W; Wasiela M; Brzezińska-Błaszczyk E
J Perinat Med; 2006; 34(5):371-7. PubMed ID: 16965223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
